VEPESID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vepesid, and what generic alternatives are available?
Vepesid is a drug marketed by Strides Pharma and Corden Pharma and is included in two NDAs.
The generic ingredient in VEPESID is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vepesid
A generic version of VEPESID was approved as etoposide by HIKMA on July 17th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VEPESID?
- What are the global sales for VEPESID?
- What is Average Wholesale Price for VEPESID?
Summary for VEPESID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 230 |
| Patent Applications: | 2,711 |
| DailyMed Link: | VEPESID at DailyMed |
Recent Clinical Trials for VEPESID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| RenJi Hospital | Phase 2 |
| Incyte Corporation | Phase 2 |
| ADC Therapeutics | Phase 2 |
US Patents and Regulatory Information for VEPESID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-001 | Dec 30, 1986 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-002 | Dec 30, 1986 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Corden Pharma | VEPESID | etoposide | INJECTABLE;INJECTION | 018768-001 | Nov 10, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VEPESID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-001 | Dec 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
| Corden Pharma | VEPESID | etoposide | INJECTABLE;INJECTION | 018768-001 | Nov 10, 1983 | ⤷ Sign Up | ⤷ Sign Up |
| Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-002 | Dec 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VEPESID
See the table below for patents covering VEPESID around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| African Intellectual Property Organization (OAPI) | 2258 | ⤷ Sign Up | |
| France | 1502813 | Nouveau dérivé de la podophyllotoxine et sa préparation | ⤷ Sign Up |
| United Kingdom | 1145909 | ⤷ Sign Up | |
| Netherlands | 6613143 | ⤷ Sign Up | |
| Finland | 44411 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
